Barclays Reaffirms Their Sell Rating on Lifestance Health Group (LFST)
LifeStance Health Gr Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Lifestance Health Group (LFST), LifeMD (LFMD)
LifeStance Health Gr Analyst Ratings
LifeStance Health Gr Analyst Ratings
Goldman Sachs Maintains Neutral on LifeStance Health Gr, Raises Price Target to $9
Lifestance Health Group Maintains Hold Rating With Limited Valuation Potential Despite Positive Trends
Barclays Adjusts LifeStance Health Group Price Target to $8 From $7, Maintains Underweight Rating
Lifestance Health Group: A Buy Rating With Promising Financial and Operational Upside
Barclays Keeps Their Sell Rating on Lifestance Health Group (LFST)
Analysts Are Bullish on These Healthcare Stocks: UnitedHealth (UNH), Lifestance Health Group (LFST)
Goldman Sachs Maintains Neutral on LifeStance Health Gr, Lowers Price Target to $8
LifeStance Health Gr Analyst Ratings
LifeStance Health Gr Analyst Ratings
Goldman Sachs Reaffirms Their Hold Rating on Lifestance Health Group (LFST)
Analysts Offer Insights on Healthcare Companies: Lifestance Health Group (LFST) and Beam Therapeutics (BEAM)
LifeStance Health Gr Analyst Ratings
LifeStance Health Gr Analyst Ratings
Goldman Sachs Maintains Neutral on LifeStance Health Gr, Raises Price Target to $9
Goldman Sachs Remains a Hold on Lifestance Health Group (LFST)